Identification of Small Molecule and Genetic Modulators of AON-Induced Dystrophin Exon Skipping by High-Throughput Screening

Debra A. O'Leary, Orzala Sharif, Paul Anderson et al. · 2009

Read Identification of Small Molecule and Genetic Modulators of AON-Induced Dystrophin Exon Skipping by High-Throughput Screening by Debra A. O'Leary, Orzala Sharif, Paul Anderson et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0008348.txt.

Description

Debra A. O'Leary and colleagues screened for muscular dystrophy drug helpers in PLOS ONE in 2009. Duchenne muscular dystrophy is a severe inherited muscle disease. One therapy idea uses antisense oligonucleotides to skip a faulty exon. Skipping converts the disease pattern toward the milder Becker form. Such trials were recently entering the clinic when the paper appeared.

The team ran high-throughput screening for modulators of exon skipping. Both small molecules and genetic modulators were sought. Boosters of skipping could make the therapy work better. The screen provides leads for combination treatments.

Catalog record

CREATORDebra A. O'Leary, Orzala Sharif, Paul Anderson et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE80 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008348

Browse the full library · About the Tower of Babel